China Medicine Stock Market Value
| CHME Stock | USD 0.04 0.00 0.00% |
| Symbol | China |
China Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to China Medicine's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of China Medicine.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in China Medicine on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding China Medicine or generate 0.0% return on investment in China Medicine over 90 days. China Medicine is related to or competes with Epigenomics, Procyon, and DATATRAK International. China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicin... More
China Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure China Medicine's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess China Medicine upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0777 | |||
| Maximum Drawdown | 90.1 | |||
| Potential Upside | 7.69 |
China Medicine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as China Medicine's standard deviation. In reality, there are many statistical measures that can use China Medicine historical prices to predict the future China Medicine's volatility.| Risk Adjusted Performance | 0.0719 | |||
| Jensen Alpha | 0.8653 | |||
| Total Risk Alpha | (0.09) | |||
| Treynor Ratio | (2.70) |
China Medicine January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0719 | |||
| Market Risk Adjusted Performance | (2.69) | |||
| Mean Deviation | 3.5 | |||
| Coefficient Of Variation | 1168.78 | |||
| Standard Deviation | 9.98 | |||
| Variance | 99.6 | |||
| Information Ratio | 0.0777 | |||
| Jensen Alpha | 0.8653 | |||
| Total Risk Alpha | (0.09) | |||
| Treynor Ratio | (2.70) | |||
| Maximum Drawdown | 90.1 | |||
| Potential Upside | 7.69 | |||
| Skewness | 1.17 | |||
| Kurtosis | 14.44 |
China Medicine Backtested Returns
China Medicine appears to be out of control, given 3 months investment horizon. China Medicine secures Sharpe Ratio (or Efficiency) of 0.0876, which signifies that the company had a 0.0876 % return per unit of risk over the last 3 months. By analyzing China Medicine's technical indicators, you can evaluate if the expected return of 0.89% is justified by implied risk. Please makes use of China Medicine's Risk Adjusted Performance of 0.0719, standard deviation of 9.98, and Mean Deviation of 3.5 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, China Medicine holds a performance score of 6. The firm shows a Beta (market volatility) of -0.31, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning China Medicine are expected to decrease at a much lower rate. During the bear market, China Medicine is likely to outperform the market. Please check China Medicine's information ratio and the relationship between the potential upside and relative strength index , to make a quick decision on whether China Medicine's price patterns will revert.
Auto-correlation | 0.03 |
Virtually no predictability
China Medicine has virtually no predictability. Overlapping area represents the amount of predictability between China Medicine time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of China Medicine price movement. The serial correlation of 0.03 indicates that only 3.0% of current China Medicine price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.03 | |
| Spearman Rank Test | 0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in China Pink Sheet
China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.